Bioqual Inc (BIOQ)
Bioqual Inc is a common stock listing on OTC Markets for Bioqual, Inc., a healthcare company focused on pre-clinical research services. Through its U.S. operations, the company works with commercial and government clients and supports studies in infectious diseases and other therapeutic areas, including AIDS, influenza, respiratory syncytial virus, coronavirus, malaria, hepatitis, cancer, and flavivirus infections such as zika and dengue. Its service line also includes small and large animal models, cell-based and immunoassays, toxicology and cytotoxicity testing, viral load testing, custom assay development, biocontainment and imaging services, animal model development, and IND-enabling work such as toxicology studies, pharmacokinetic profiling, GLP services, and regulatory documentation. Bioqual, Inc. was incorporated in 1981 and is based in Rockville, Maryland.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
OTC-BIOQ
|
$28.82
|
-11.3% Downside
|
Fair
|
—
|
—
|
—
|
Good
|
—
|
—
|
—
|
0.0%
|
September 18, 2026
|
-23.5x
|
0.8x
|
0.7x
|
29.069 M
|
44.756 M
|
53.5%
|
23.0%
|
1.9
|
0.0%
|
-480.7%
|
